Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

New model predicts cognitive decline of patients at risk for Alzheimer’s disease

A new model developed at MIT can help predict if patients at risk for Alzheimer's disease will experience clinically significant cognitive decline due to the disease, by predicting their cognition test scores up to two years in the future.

2 Aug 2019

Scientist wins two-year grant for diagnosis of Alzheimer's, Parkinson's via innovative skin test

Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.

2 Aug 2019

Blood test may accurately identify people with early Alzheimer's brain changes

Up to two decades before people develop the characteristic memory loss and confusion of Alzheimer's disease, damaging clumps of protein start to build up in their brains.

2 Aug 2019

Alzheimers may be linked to genes that code formation of contacts between neurons

A team of neurobiologists from Peter the Great St. Petersburg Polytechnic University published an article on their study of the causes of Alzheimer's disease and suggested therapy methods.

2 Aug 2019

Super-resolution microscopy helps unravel elusive causes of dementia

University of Queensland researchers have used super-resolution microscopy to observe key molecules at work inside living brain cells, further unraveling the puzzle of memory formation and the elusive causes of dementia.

2 Aug 2019

Prion disease in mice treated successfully with antisense oligonucleotides

Prion proteins are known to cause scrapie – a neurodegenerative condition. It is capable of debilitating damage to the nervous system. Researchers have successfully devised a treatment for this condition which prolonged the lives of the lab mice infected with the prions.

1 Aug 2019

Low or high levels of hemoglobin may increase risk of dementia

Having either low or high levels of hemoglobin in your blood may be linked to an increased risk of developing dementia years later, according to a study published in the July 31, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

1 Aug 2019

Mice brain study reveals secrets about Alzheimer’s

Researchers from University of California, Irvine have found the key responses of brain cells to Alzheimer’s disease (AD) and say that this could help them understand the chronic debilitating and progressive neurodegenerative disease better in future.

1 Aug 2019

Liver function may be important in Alzheimer’s disease risk

A new study shows a strong link between altered liver function and the development of Alzheimer’s disease (AD). This correlates with recent data on the role played by diseases affecting the systemic metabolism, such as diabetes and high blood cholesterol, in disruptions of brain function as in AD.

31 Jul 2019

Important steps to slow down Alzheimer's disease

Alzheimer's Disease is the most common type of dementia. It slowly kills brain cells and is the fifth-leading cause of death for Americans age 65 and over.

31 Jul 2019

Research uncovers novel connections between liver dysfunction and Alzheimer's disease

New research from the Alzheimer's Disease Metabolomics Consortium and Alzheimer's Disease Neuroimaging Initiative has uncovered novel connections between liver dysfunction and Alzheimer's disease, paving a new path toward a systems level view of Alzheimer's relevant for early detection and ultimately for prevention.

31 Jul 2019

Traditional measures overlook socioeconomic costs associated with dementia

A new research review highlighting the hidden costs of dementia suggests that traditional measures only show the 'tip of the iceberg' of the cost impact on society.

31 Jul 2019

UC Berkeley awarded $47 million grant to study how healthy lifestyle changes the aging brain

The University of California, Berkeley announced today that it has received a five-year grant expected to total $47 million from the U.S. National Institute on Aging (NIA) to incorporate advanced brain imaging into the Alzheimer's Association's groundbreaking clinical trial, the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER), to determine whether lifestyle changes can protect memory in people at risk of developing dementia.

29 Jul 2019

Creator of brain exam that Trump aced demands new training for testers

Last year, Dr. Ronny Jackson, then the White House physician, gave Donald Trump a standard test to detect early signs of dementia — and said the president had scored a perfect 30.

29 Jul 2019

Bigger waists and higher BMI in 60s may be linked to greater brain aging years later

Having a bigger waistline and a high body mass index in your 60s may be linked with greater signs of brain aging years later, according to a study published in the July 24, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

25 Jul 2019

Weak electron attraction helps hold together amyloid beta sheets found in Alzheimer's

The chemical interactions that give proteins their shape may be weaker and more numerous than previously recognized. These weak connections provide a new way for researchers to understand proteins that cause disease and help them gain insights into the fundamentals of chemistry.

24 Jul 2019

Altered protein and mutated clusters of genes in Alzheimer’s disease

Alzheimer's disease (AD) diagnosis and treatment has been a challenge and this is mainly due to the varying degrees of degeneration and cognitive damage seen in different patients. The researchers from the University of California San Diego School of Medicine for the first time used the transcriptome to assess the proteins made from the genes in patients with AD, that could help in diagnosis.

23 Jul 2019

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

The Alzheimer's Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, a $3 million grant to be applied to the company's mesenchymal stem cell Alzheimer's research.

23 Jul 2019

ADHD in athletes may be linked to longer recovery time from concussions

For college athletes, having attention deficit hyperactivity disorder (ADHD) may be linked to increased symptoms, and longer recovery time from concussions, according to a preliminary study released today that will be presented at the American Academy of Neurology Sports Concussion Conference in Indianapolis July 26-28.

22 Jul 2019

Eisai presents new research evaluating correlation of Abeta in plasma and CSF with automated protein assay system

Eisai Co.,Ltd. announced its latest research on evaluation about correlation of amyloid beta (Abeta) in plasma and in cerebrospinal fluid (CSF) by high precision measurement with the newly developed automated protein assay system, jointly developed with Sysmex Corporation, using full automated immunoassay system HISCLTM series for creating the simplified diagnosis of Alzheimer's disease with blood was presented at the Alzheimer's Association International Conference held in Los Angeles, California, United States, from July 14 to 18, 2019.

From Eisai 19 Jul 2019

Alzheimer's Disease News and Research

Further Reading

New model predicts cognitive decline of patients at risk for Alzheimer’s disease

Scientist wins two-year grant for diagnosis of Alzheimer's, Parkinson's via innovative skin test

Blood test may accurately identify people with early Alzheimer's brain changes

Alzheimers may be linked to genes that code formation of contacts between neurons

Super-resolution microscopy helps unravel elusive causes of dementia

Prion disease in mice treated successfully with antisense oligonucleotides

Low or high levels of hemoglobin may increase risk of dementia

Mice brain study reveals secrets about Alzheimer’s

Liver function may be important in Alzheimer’s disease risk

Important steps to slow down Alzheimer's disease

Research uncovers novel connections between liver dysfunction and Alzheimer's disease

Traditional measures overlook socioeconomic costs associated with dementia

UC Berkeley awarded $47 million grant to study how healthy lifestyle changes the aging brain

Creator of brain exam that Trump aced demands new training for testers

Bigger waists and higher BMI in 60s may be linked to greater brain aging years later

Weak electron attraction helps hold together amyloid beta sheets found in Alzheimer's

Altered protein and mutated clusters of genes in Alzheimer’s disease

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

ADHD in athletes may be linked to longer recovery time from concussions

Eisai presents new research evaluating correlation of Abeta in plasma and CSF with automated protein assay system

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News